Efficacy and Safety Study of Essential Oil-Based Preparation Administered to COVID-19 Patients

Publication date: Jun 13, 2024

The aim of this study was to compare the efficacy and safety of the essential oil-based product in patients with mild to moderate symptomatic COVID-19 Positive infection confirmed by PCR. A computational simulation approach of the molecular interaction (binding) of the main components of essential oils exhibiting antiviral activity with known intracellular protein targets of SARS-CoV-2 (nsp5: Main Protease) was adopted as a rationale for this study. SARS-CoV-2, a single-stranded RNA virus, has four major structural proteins Spike (S), Membrane (M), Envelope glycoprotein (E) and Nucleocapsid (N) protein and non-structural proteins (nsp). These non-structural proteins, of which there are 16 in total in the genome of the virus, play key roles in the mechanisms of the virus life cycle, including replication, transcription, protein synthesis and modification of RNA. Main protease (Main protease, Mpro, 3CLpro), virus Since they are directly involved in the maturation of these nsp proteins, which have an important role in many mechanisms of the life cycle, they have been the target enzyme in the development of new antiviral drugs for the treatment of COVID-19. In this study, our main rationale is to investigate the effect of essential oils on nsp5: Main Protease enzyme activations.

Concepts Keywords
Fungi Activity
Lipophilicity Antiviral
Master Cov
Oil Covid
Viral Essential
Main
Membrane
Non
Nsp5
Oils
Protease
Rationale
Sars
Structural
Virus

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease VO Glycoprotein
disease IDO replication

Original Article

(Visited 5 times, 1 visits today)